Supercharged sprout vitamin inspiration for new Alzheimer's drug research

December 23, 2016
Supercharged sprout vitamin inspiration for new Alzheimer's drug research
A supercharged version of the acid derived from our Christmas dinner veg is the basis of new research aimed at developing a new drug to treat Alzheimer’s. Credit: University of Aberdeen

A supercharged version of the acid derived from our Christmas dinner veg is the basis of new research aimed at developing a new drug to treat Alzheimer's disease.

Experts at the University of Aberdeen are working on a of the beneficial acid created from vitamin A – a vitamin your body can get from eating a number of vegetables, including carrots and sprouts – which they hope may be used to treat neurological disorders.

In the body vitamin A is turned Into , which then interacts with specific receptors in the brain and plays a role in the development of the human central nervous system. It is particularly important for the eye and brain as the embryo is developing.

In the adult brain it is thought retinoic acid plays a different, more 'focussed' role and there are suggestions it could affect neural disorders, both degenerative and psychiatric.

Now, University of Aberdeen experts, in conjunction with the University of Durham and chemical development company High Force Research are set to begin a new two year, £250,000 project funded by the Biotechnology and Biological Sciences Research Council (BBSRC).

The researchers have designed synthetic versions of retinoic acid that interact with the body's natural receptors in the brain in an even more powerful way than regular retinoic acid.

The video will load shortly

The team hope to progress the research to develop therapeutics– primarily for Alzheimer's but potentially Parkinson's disease and other neurodegenerative diseases.

Another unique aspect of the Aberdeen-led study is the method used to screen the new synthetic compounds making the process more efficient.

With the cost of drug discovery rising and the time to develop new drugs increasing, this new process is another important factor that contributed to the project being identified for further funding.

Professor Peter McCaffery, who is leading the project said: "We are basically trying to create a massively amplified version of what vitamin A already does for the body. By exploiting the natural consequences of retinoic acid by creating a synthetic alternative, we hope to be able to create a new therapeutic which could be used to help people with Alzheimer's disease.

"There are other projects of a similar nature but they are focussed on different receptors and we are confident that our compound will prove to be more successful. Added to that, our unique screening process is an exciting innovation which should increase the efficiency of the process and could have implications beyond this particular project."

Explore further: Vitamin A affects the heart, not just eyes and skin

Related Stories

Vitamin A affects the heart, not just eyes and skin

May 2, 2016

Vitamin A is involved in many bodily processes, including vision and skin health, but its role in the heart is unclear. While vitamin A is critical for heart development of embryos—vitamin A deficiency during pregnancy ...

Previously unknown effect of vitamin A identified

February 24, 2015

The signal molecule, retinoic acid, is a product of vitamin A which helps to instruct how different types of tissue are to be formed in the growing embryo. For the first time, Professor Niels-Bjarne Woods' laboratory, Lund ...

Researcher suggests enzyme crucial to embryonic development

September 10, 2013

(Medical Xpress)—Scientists have long recognized retinoic acid – a compound the body produces by metabolizing vitamin A – as crucial to embryonic development. Either too much or too little retinoic acid during gestation ...

Recommended for you

In Alzheimer's, excess tau protein damages brain's GPS

January 19, 2017

Columbia University Medical Center (CUMC) researchers have discovered that the spatial disorientation that leads to wandering in many Alzheimer's disease patients is caused by the accumulation of tau protein in navigational ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PPihkala
not rated yet Dec 27, 2016
They can't patent retinoic acid, so they have to make their own. In the mean while, this does suggest that vitamin A levels should be checked and kept high, if such brain problems are suspected. I have long suspected that lot's of degenerative symptoms have roots in inadequate intake of different vitamins and minerals. We just don't have cheap, easy methods to measure those from people and on top of that we don't really know the healthy levels needed daily.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.